A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you’re just getting started. While ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

Another major development from HIMS in recent months includes the announcement of access to the most common compounded GLP-1 subscriptions for $99 monthly for eligible ... schedules and dosing for ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

If you're interested in a short-term CD that will let you lock in a good interest rate, 6-month CDs could be a good choice. The national average CD rate on a 6-month term is 1.75% APY (Annual ...